Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Clin Cancer Res. 2010 Jul 20;16(19):4742–4754. doi: 10.1158/1078-0432.CCR-10-0529

Figure 3. Treatment with Panobinostat induces ER stress, results in dose-dependent apoptosis and abrogates hsp90 client proteins in MCL cells.

Figure 3

A, JeKo-1 and Z18C cells were treated with indicated doses of PS for 6 hours and the mRNA expression of XBP1s, XBP1u, Erdj4, CHOP and NOXA was assessed by RT-PCR. The expression of β-actin served as a loading control. B, JeKo-1 and Z138C cells were treated with indicated doses of PS for 6 hours and the expression of ATF4, GRP78 and CHOP was assessed by immunoblotting. C, JeKo-1, MO2058, Z138C and Granta-519 cells were exposed to the indicated doses of PS for 48 hours and apoptosis was monitored by Annexin V and PI staining followed by flow cytometry. D, JeKo-1 cells were exposed to indicated doses of PS for 6 hours and the expression of c-RAF, AKT, Cyclin D1, CDK, survivin, c-Myc, BAK, BAX and β-actin were monitored by immunoblot analyses.

HHS Vulnerability Disclosure